Apical Ischemia Is a Universal Feature of Apical Hypertrophic Cardiomyopathy. (21st March 2023)

• Record Type: Journal Article
• Authors: Hughes, Rebecca K.; Augusto, João B.; Knott, Kristopher; Davies, Rhodri; Shiwani, Hunain; Seraphim, Andreas; Malcolmson, James W.; Khoury, Shafik; Joy, George; Mohiddin, Saidi; Lopes, Luis R.; McKenna, William J.; Kellman, Peter; Xue, Hui; Tome, Maite; Sharma, Sanjay; Captur, Gabriella; Moon, James C.
• Is Part Of: Circulation. Volume 16:Number 3(2023)
• Page Start: e014907
• Publication Date: 2023-03-21
• Subjects: apical hypertrophic cardiomyopathy -- cardiomyopathy -- humans -- hypertrophic -- hypertrophy -- stroke volume; Cardiovascular system -- Imaging -- Periodicals; Heart -- Imaging -- Periodicals; 616.1075405
• DOI: 10.1161/CIRCIMAGING.122.014907
• Languages: English
• ISSNs: 1941-9651

Abstract

Abstract : Background: Apical hypertrophic cardiomyopathy (ApHCM) accounts for ≈10% of hypertrophic cardiomyopathy cases and is characterized by apical hypertrophy, apical cavity obliteration, and tall ECG R waves with ischemic-looking deep T-wave inversion. These may be present even with <15 mm apical hypertrophy (relative ApHCM). Microvascular dysfunction is well described in hypertrophic cardiomyopathy. We hypothesized that apical perfusion defects would be common in ApHCM. Methods: A 2-center study using cardiovascular magnetic resonance short- and long-axis quantitative adenosine vasodilator stress perfusion mapping. One hundred patients with ApHCM (68 overt hypertrophy [≥15 mm] and 32 relative ApHCM) were compared with 50 patients with asymmetrical septal hypertrophy hypertrophic cardiomyopathy and 40 healthy volunteer controls. Perfusion was assessed visually and quantitatively as myocardial blood flow and myocardial perfusion reserve. Results: Apical perfusion defects were present in all overt ApHCM patients (100%), all relative ApHCM patients (100%), 36% of asymmetrical septal hypertrophy hypertrophic cardiomyopathy, and 0% of healthy volunteers ( P <0.001). In 10% of patients with ApHCM, perfusion defects were sufficiently apical that conventional short-axis views missed them. In 29%, stress myocardial blood flow fell below rest values. Stress myocardial blood flow was most impaired subendocardially, with greater hypertrophy or scar, and with apical aneurysms. Impaired apical myocardial blood flow was most strongly predicted by thicker apical segments (β-coefficient, −0.031 mL/g per min [CI, −0.06 to −0.01]; P =0.013), higher ejection fraction (−0.025 mL/g per min [CI, −0.04 to −0.01]; P <0.005), and ECG maximum R-wave height (−0.023 mL/g per min [CI, −0.04 to −0.01]; P <0.005). Conclusions: Apical perfusion defects are universally present in ApHCM at all stages. Its ubiquitous presence along with characteristic ECG suggests ischemia may play a disease-defining role in ApHCM.